Marc S. Schneider, M.D., P.A. – Trademark Portfolio
Entity Type: 99
Marc S. Schneider, M.D., P.A. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include MYGENICS. The owner is based in Naples, FL.
3838 Tamiami Trail North, Suite 310
c/o WHITELAW LEGAL GROUP
Naples, FL 34103
Showing of trademarks Trademarks
Trademark Classifications
Marc S. Schneider, M.D., P.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Marc S. Schneider, M.D., P.A. have?
Marc S. Schneider, M.D., P.A. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 2 abandoned, 1 cancelled.
What trademark classes does Marc S. Schneider, M.D., P.A. file in?
Marc S. Schneider, M.D., P.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Marc S. Schneider, M.D., P.A.'s most well-known trademarks?
Marc S. Schneider, M.D., P.A.'s registered trademark portfolio includes well-known marks such as MYGENICS. These are among 1 currently registered trademark in the portfolio.
What is Marc S. Schneider, M.D., P.A.'s trademark registration success rate?
Marc S. Schneider, M.D., P.A. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.